EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Alternative splicing mediates the compensatory upregulation of MBNL2 upon MBNL1 loss-of-function

Larissa Nitschke, Rong-Chi Hu, Andrew N Miller, Lathan Lucas, Thomas A Cooper iD

Nucleic Acids Research · 2023

DOI: 10.1093/nar/gkac1219 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Nucleic Acids Research, 2023. Verfasst von Larissa Nitschke und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology & Immunology, Baylor College of Medicine, Houston, TX 77030, USA. Hauptthemen laut MEDLINE: Alternative Splicing, Myotonic Dystrophy, RNA-Binding Proteins. Die Arbeit wurde bisher 33-mal zitiert (Crossref) und nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: NCI NIH HHS, NIAMS NIH HHS, NHLBI NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Loss of gene function can be compensated by paralogs with redundant functions. An example of such compensation are the paralogs of the Muscleblind-Like (MBNL) family of RNA-binding proteins that are sequestered and lose their function in Myotonic Dystrophy Type 1 (DM1). Loss of MBNL1 increases the levels of its paralog MBNL2 in tissues where Mbnl2 expression is low, allowing MBNL2 to functionally compensate for MBNL1 loss. Here, we show that loss of MBNL1 increases the inclusion of Mbnl2 exon 6 and exon 9. We find that inclusion of Mbnl2 exon 6 increases the translocation of MBNL2 to the nucleus, while the inclusion of Mbnl2 exon 9 shifts the reading frame to an alternative C-terminus. We show that the C-terminus lacking exon 9 contains a PEST domain which causes proteasomal degradation. Loss of MBNL1 increases the inclusion of exon 9, resulting in an alternative C-terminus lacking the PEST domain and the increase of MBNL2. We further find that the compensatory mechanism is active in a mouse DM1 model. Together, this study uncovers the compensatory mechanism by which loss of MBNL1 upregulates its paralog MBNL2 and highlights a potential role of the compensatory mechanism in DM1.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Alternative SplicingMyotonic DystrophyRNA-Binding ProteinsAnimalsMiceDNA-Binding ProteinsExonsTranscriptional ActivationUp-Regulation

Substanzen

DNA-Binding ProteinsMbnl1 protein, mouseRNA-Binding ProteinsMbnl2 protein, mouse

Autor:innen und Institutionen

  • Department of Pathology & Immunology, Baylor College of Medicine, Houston, TX 77030, USA.
  • Department of Molecular Physiology & Biophysics, Baylor College of Medicine, Houston, TX 77030, USA.
  • Chemical, Physical & Structural Biology Graduate Program, Baylor College of Medicine, Houston, TX 77030, USA.
  • Department of Molecular & Cellular Biology, Baylor College of Medicine, Houston, TX 77030, USA.

ORCID-Profile: Thomas A Cooper

Förderung

  • NCI NIH HHS
  • NIAMS NIH HHS
  • NHLBI NIH HHS
  • National Institutes of Health
  • Myotonic Dystrophy Foundation

Zitieren

APA

Nitschke, L., Hu, R. C., Miller, A. N., Lucas, L., & Cooper, T. A. (2023). Alternative splicing mediates the compensatory upregulation of MBNL2 upon MBNL1 loss-of-function. Nucleic Acids Research. https://doi.org/10.1093/nar/gkac1219

Vancouver

Nitschke L, Hu RC, Miller AN, Lucas L, Cooper TA. Alternative splicing mediates the compensatory upregulation of MBNL2 upon MBNL1 loss-of-function. Nucleic Acids Research. 2023. doi:10.1093/nar/gkac1219

BibTeX
@article{Nitschke2023,
  author = {Nitschke, Larissa and Hu, Rong-Chi and Miller, Andrew N and Lucas, Lathan and Cooper, Thomas A},
  title = {Alternative splicing mediates the compensatory upregulation of MBNL2 upon MBNL1 loss-of-function},
  journal = {Nucleic Acids Research},
  year = {2023},
  doi = {10.1093/nar/gkac1219}
}
Kostenlos starten →